Use of methotrexate in the treatment of moderate to severe plaque psoriasis in France: A practice survey
Clinical, Cosmetic and Investigational Dermatology | Apr 28, 2021
Randomized, double‐blind, active‐controlled, multicentre, phase III clinical trial with two stages to assess the safety and efficacy of letibotulinum toxin a vs onabotulinum toxin a for subjects with moderate to severe crow's feet
Journal of the European Academy of Dermatology and Venereology | Apr 17, 2021
Most read this week